Haile, Y., Seylani, A., Sadighian, A. (2025). Five-year survival outcomes in NSCLC patients with concurrent GERD on proton pump inhibitors receiving pembrolizumab or nivolumab: A global study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e20611